(Q45396018)

English

MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection

scientific article published on 4 April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection (English)

1 reference

Europe PubMed Central

14 December 2017

0 references

Hepatitis B virus

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

chronic hepatitis B

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

Young Joon Yoon

1

1 reference

Europe PubMed Central

14 December 2017

Hye Young Chang

2

1 reference

Europe PubMed Central

14 December 2017

Sang Hoon Ahn

3

1 reference

Europe PubMed Central

14 December 2017

Ja Kyung Kim

4

1 reference

Europe PubMed Central

14 December 2017

Yong Kwang Park

5

1 reference

Europe PubMed Central

14 December 2017

Dae Ryong Kang

6

1 reference

Europe PubMed Central

14 December 2017

Jun Yong Park

7

1 reference

Europe PubMed Central

14 December 2017

Sung Min Myoung

8

1 reference

Europe PubMed Central

14 December 2017

Do Young Kim

9

1 reference

Europe PubMed Central

14 December 2017

Chae Yoon Chon

10

1 reference

Europe PubMed Central

14 December 2017

Kwang-Hyub Han

11

1 reference

Europe PubMed Central

14 December 2017

language of work or name

0 references

publication date

4 April 2008

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

29

1 reference

Europe PubMed Central

14 December 2017

1192-1196

1 reference

Europe PubMed Central

14 December 2017

6

1 reference

Europe PubMed Central

14 December 2017

Estimating the world cancer burden: Globocan 2000.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

Hepatocellular carcinoma: epidemiology, risk factors, and screening

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

Hepatocellular carcinoma and hepatitis B virus

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

How to predict HCC development in patients with chronic B viral liver disease?

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

Hepatocellular carcinoma: the high-risk patient

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

Single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

Homozygosity for Pro of p53 Arg72Pro as a potential risk factor for hepatocellular carcinoma in Chinese population

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

Association between hepatitis B virus infection and HLA-DR type in Korea

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

MDM2 309T>G polymorphism and risk of lung cancer in a Korean population.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

TP53 and liver carcinogenesis.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

Two polymorphic variants of wild-type p53 differ biochemically and biologically

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

The codon 72 polymorphic variants of p53 have markedly different apoptotic potential

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

The MDM2 promoter polymorphism SNP309T-->G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

The role of P53 and MDM2 polymorphisms in the risk of esophageal squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

No association between the MDM2 -309 T/G promoter polymorphism and breast cancer in African-Americans or Whites

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

Frequent loss of p53 codon 72 Pro variant in hepatitis C virus-positive carriers with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

p53 Codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

Chilean pilot study on the risk of lung cancer associated with codon 72 polymorphism in the gene of protein p53.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

p53 polymorphisms and haplotypes in breast cancer.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

Prognostic significance of the proline form of p53 codon 72 polymorphism in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

Serological markers of liver cancer.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN090

21 January 2018

Identifiers

10.1093/CARCIN/BGN090

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45396018&oldid=2076550443"